observed a significantly lower level of acetylated HSP90 (acetyl-HSP90) in PBMCs from AD patients compared to controls, while treatment of human keratinocytes (HaCaT cells) with 17-AAG led to increased acetylation of HSP90. The gene discussed is HSP90AB1; the disease is Alzheimer disease.